- Home
- TENX vs CING Comparison
TENX vs CING Comparison
Compare TENX & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- CING
- Stock Information
- Founded
- TENX 1967
- CING 2012
- Country
- TENX United States
- CING United States
- Employees
- TENX N/A
- CING N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- TENX Health Care
- CING Health Care
- Exchange
- TENX Nasdaq
- CING Nasdaq
- Market Cap
- TENX 25.0M
- CING 26.7M
- IPO Year
- TENX N/A
- CING 2021
- Fundamental
- Price
- TENX $5.99
- CING $3.99
- Analyst Decision
- TENX Strong Buy
- CING Strong Buy
- Analyst Count
- TENX 3
- CING 4
- Target Price
- TENX $15.00
- CING $31.00
- AVG Volume (30 Days)
- TENX 15.7K
- CING 168.8K
- Earning Date
- TENX 08-13-2025
- CING 08-19-2025
- Dividend Yield
- TENX N/A
- CING N/A
- EPS Growth
- TENX N/A
- CING N/A
- EPS
- TENX N/A
- CING N/A
- Revenue
- TENX N/A
- CING N/A
- Revenue This Year
- TENX N/A
- CING N/A
- Revenue Next Year
- TENX N/A
- CING N/A
- P/E Ratio
- TENX N/A
- CING N/A
- Revenue Growth
- TENX N/A
- CING N/A
- 52 Week Low
- TENX $3.25
- CING $3.02
- 52 Week High
- TENX $7.89
- CING $9.69
- Technical
- Relative Strength Index (RSI)
- TENX 51.19
- CING 42.98
- Support Level
- TENX $5.88
- CING $3.88
- Resistance Level
- TENX $6.02
- CING $4.43
- Average True Range (ATR)
- TENX 0.13
- CING 0.32
- MACD
- TENX -0.01
- CING 0.00
- Stochastic Oscillator
- TENX 70.37
- CING 52.69
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.